Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.

OBJECTIVE To identify factors associated with substance misuse in first-episode patients with schizophrenia or schizoaffective disorder. METHOD Twenty-seven patients with a past or current history of substance misuse were compared with 91 patients with no history of misuse on demographic and psychopathological measures before being treated for their first episode of psychosis, and on cognitive measures after 6 months of treatment. RESULTS There were no statistically significant differences between groups for sex, schizophrenia subtype, marital status, education, family history of schizophrenia, course of illness, age of onset, baseline symptoms, time to treatment response, medication side effects, attention span, memory and executive functioning. However, dual diagnosis patients were found to have a higher parental social class, better premorbid cognitive functioning, higher IQ and better language skills. CONCLUSION First-episode patients with a history of substance misuse have higher intellectual functioning, which may be associated with higher premorbid socioeconomic status and cognitive functioning.

[1]  E. O'callaghan,et al.  The prevalence of comorbid substance misuse and its influence on suicidal ideation among in‐patients with schizophrenia , 2000, Acta psychiatrica Scandinavica.

[2]  J. Lieberman,et al.  Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. , 2000, The American journal of psychiatry.

[3]  J. Lieberman,et al.  Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. , 1999, Archives of general psychiatry.

[4]  J. Schwartz,et al.  Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients , 1998, Psychological Medicine.

[5]  J. Addington,et al.  Effect of substance misuse in early psychosis , 1998, British Journal of Psychiatry.

[6]  R. Heslegrave,et al.  Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse. , 1997, The Journal of nervous and mental disease.

[7]  D. Jeste,et al.  Movement disorders and substance abuse. , 1997, Psychiatric services.

[8]  J. Addington,et al.  Substance abuse and cognitive functioning in schizophrenia. , 1997, Journal of psychiatry & neuroscience : JPN.

[9]  H. Häfner,et al.  Substance abuse and the onset of schizophrenia , 1996, Biological Psychiatry.

[10]  R. Owen,et al.  Medication noncompliance and substance abuse among patients with schizophrenia. , 1996, Psychiatric services.

[11]  S. Bhatia,et al.  Relapse in schizophrenia: is there a relationship to substance abuse? , 1996, Schizophrenia Research.

[12]  Lawrence B. Inderbitzin,et al.  Substance use: a powerful predictor of relapse in schizophrenia , 1996, Schizophrenia Research.

[13]  S Pollack,et al.  Subject selection biases in clinical trials: data from a multicenter schizophrenia treatment study. , 1996, Journal of clinical psychopharmacology.

[14]  Jeffrey A. Lieberman,et al.  Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia , 1995, Schizophrenia Research.

[15]  H. Silver,et al.  Drug abuse in schizophrenia: comparison of patients who began drug abuse before their first admission with those who began abusing drugs after their first admission , 1994, Schizophrenia Research.

[16]  R. Tandon,et al.  Patterns of substance abuse in schizophrenia: nature and significance. , 1994, Journal of psychiatric research.

[17]  D. Ziedonis,et al.  Nicotine dependence and schizophrenia. , 1994, Hospital & community psychiatry.

[18]  C. Adamsson,et al.  Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County , 1993, Acta psychiatrica Scandinavica.

[19]  J. Schwartz,et al.  Substance abuse and onset of psychotic illness. , 1993, Hospital & community psychiatry.

[20]  J. Lieberman,et al.  Time course and biologic correlates of treatment response in first-episode schizophrenia. , 1993, Archives of general psychiatry.

[21]  P. Dingemans,et al.  Cannabis abuse and the course of recent onset schizophrenic disorders , 1993, Schizophrenia Research.

[22]  K. Mueser,et al.  Comorbidity of schizophrenia and substance abuse : implications for treatment , 1992 .

[23]  N. Andreasen,et al.  Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment , 1992, Psychological Medicine.

[24]  D. Braff,et al.  Past substance abuse and clinical course of schizophrenia. , 1992 .

[25]  J. Sweeney,et al.  Drug abuse in schizophrenic patients: clinical correlates and reasons for use. , 1991, The American journal of psychiatry.

[26]  D S Rae,et al.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.

[27]  L. Opler,et al.  Significance of Cocaine History in Schizophrenia , 1990, The Journal of nervous and mental disease.

[28]  K. Brady,et al.  Cocaine abuse among schizophrenic patients. , 1990, The American journal of psychiatry.

[29]  R. Drake,et al.  Alcohol Use and Abuse in Schizophrenia: A Prospective Community Study , 1989, The Journal of nervous and mental disease.

[30]  J G Barbee,et al.  Alcohol and Substance Abuse among Schizophrenic Patients Presenting to an Emergency Psychiatric Service , 1989, The Journal of nervous and mental disease.

[31]  P. Allebeck,et al.  Schizophrenia in users and nonusers of cannabis , 1989, Acta psychiatrica Scandinavica.

[32]  D. T. Latimer-Sayer,et al.  DRUG ABUSE AND MENTAL ILLNESS , 1988, The Lancet.

[33]  T. Roth,et al.  Sleepiness and motor vehicle accidents. , 1988, International clinical psychopharmacology.

[34]  H. Sackeim,et al.  Neuropsychological deterioration and CT scan findings in chronic schizophrenia , 1988, Schizophrenia Research.

[35]  Sven Andréasson,et al.  CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts , 1987, The Lancet.

[36]  F. Schneier,et al.  A Review of Psychoactive Substance Use and Abuse in Schizophrenia: Patterns of Drug Choice , 1987, The Journal of nervous and mental disease.

[37]  H. Merskey,et al.  Correlates of Suicide Attempts and Ideation in Schizophrenia , 1987, British Journal of Psychiatry.

[38]  N C Andreasen,et al.  Negative v positive schizophrenia. Definition and validation. , 1982, Archives of general psychiatry.

[39]  M. Tsuang,et al.  Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history. , 1982, Archives of general psychiatry.

[40]  J. Endicott,et al.  A diagnostic interview: the schedule for affective disorders and schizophrenia. , 1978, Archives of general psychiatry.

[41]  J. Strauss,et al.  Prognostic implications of various drinking patterns in psychiatric patients. , 1977, The American journal of psychiatry.

[42]  P. McHugh,et al.  Hallucinogenic drugs as precipitants of schizophrenia , 1974, Psychological Medicine.

[43]  G. Simpson,et al.  A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.

[44]  J. Lieberman,et al.  Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. , 1992, Schizophrenia bulletin.

[45]  C. Mazure,et al.  Psychotogenic drug use and neuroleptic response. , 1990, Schizophrenia bulletin.

[46]  J. Sweeney,et al.  Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. , 1990, Schizophrenia bulletin.

[47]  J. Brady.  Alcohol and the Writer , 1990 .

[48]  D. Levinson,et al.  Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. , 1990, Schizophrenia bulletin.

[49]  J. Lieberman,et al.  Dopaminergic mechanisms in idiopathic and drug-induced psychoses. , 1990, Schizophrenia bulletin.

[50]  S. Siris.  Pharmacological treatment of substance-abusing schizophrenic patients. , 1990, Schizophrenia bulletin.

[51]  L. Aiken.  Retrospective self-reports by clients differ from original reports: implications for the evaluation of drug treatment programs. , 1986, The International journal of the addictions.

[52]  R. Bilder,et al.  Symptomatic and neuropsychological components of defect states. , 1985, Schizophrenia bulletin.

[53]  R. Wyatt,et al.  Measurement of premorbid adjustment in chronic schizophrenia. , 1982, Schizophrenia bulletin.

[54]  Fredrick C. Redlich,et al.  Social class and mental illness: Community study. , 1958 .